China Nuokang Bio-Pharma

^{, Nasdaq: NKBP}

Leading provider of blood-clotting medication in China.

Industry: Health Care

First Day Return: -3.7%

NKBP

Leading provider of blood-clotting medication in China.

IPO News for China Nuokang Bio-Pharma

China Nuokang quiet period ends January 18 01/13/10
Four of eight planned IPOs this week complete deals 12/11/09
China Nuokang prices IPO at $9.00, below the range 12/10/09

IPO Data
IPO Date	12/09/2009
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$45
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.nkbp.com
Headquarters	Shenyang, Liaoning Province, China
Founded	1997
Employees at IPO	n/a

IPO News for China Nuokang Bio-Pharma

China Nuokang quiet period ends January 18 01/13/10
Four of eight planned IPOs this week complete deals 12/11/09
China Nuokang prices IPO at $9.00, below the range 12/10/09

China Nuokang Bio-Pharma (NKBP) Performance